Clinical Trial Update: Efficacy and Safety Study of PEX168 in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating PEX168 in combination with metformin for type 2 diabetes mellitus; no results reported yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• PEX168 (PEX168)
• metformin (metformin)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: UNKNOWN